# Endocrinology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: George H. W. Bush (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML018-SYN
- Date: 2026-05-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Anjali Kapoor, MD
- Calendar frame: modern shifted

- Requested by: Douglas Whitford, MD

## Reason for consultation

New paroxysmal atrial fibrillation in a fit 66-year-old, with thyroid tests showing hyperthyroidism and a positive TSH receptor antibody. Please confirm Graves' disease, assess the eyes, and advise on definitive treatment and on the thyroid course afterwards. **S**

## History

Mr. Bush is seen at the request of Dr. Whitford, twelve days after starting methimazole 20 mg daily. Before the atrial fibrillation he had noticed more tiredness on his runs, and some weight loss despite a good appetite. He feels better on methimazole and metoprolol. He has had no neck pain, recent viral illness, iodine contrast, or amiodarone, and no eye pain, grittiness, bulging, or double vision. He has had no methimazole side effects. He has never used tobacco. He wants a treatment that settles the problem quickly so he can get back to running and a full schedule. **S**

## Examination

| System | Finding |
|---|---|
| General | Well and calm |
| Eyes | No lid retraction, lid lag, proptosis, chemosis, or redness; eye movements full; clinical activity score 0 |
| Neck | Diffusely enlarged, non-tender thyroid without nodules; no bruit |
| Cardiovascular | Regular rhythm at 72 per minute |
| Neurological | Fine tremor of the outstretched hands |

BP 132/70 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.9 °C; oxygen saturation 98% on room air; weight 86.4 kg; BMI 24.4 kg/m². All vital signs are synthetic.

## Data reviewed

The hospital ECG and echocardiogram, the intake thyroid tests and TSH receptor antibody, the baseline blood count and liver and kidney tests, and today's free T4, total T3, TSH, neutrophil count, and ALT. TSH: 0.01 mIU/L (low); Free T4: 2.2 ng/dL (high); Total T3: 176 ng/dL; Absolute neutrophil count: 3.5 10*3/uL; ALT: 30 U/L. All results are synthetic.

## Assessment

1. **Graves' disease with hyperthyroidism** (E05.00). Confirmed: suppressed TSH with raised free T4 and total T3, a positive TSH receptor antibody, and a diffuse goiter. No uptake scan is needed. Responding to methimazole: free T4 2.2 ng/dL, total T3 176 ng/dL. Neutrophils and ALT are normal. **S**
2. **Graves' orbitopathy**. None (clinical activity score 0). As a never smoker without eye disease, his risk of new or worse eye disease after radioactive iodine is low, and steroid cover is not needed. **S**
3. **Atrial fibrillation triggered by thyrotoxicosis** (I48.0). In sinus rhythm on metoprolol. Most thyrotoxic atrial fibrillation does not recur once thyroid levels are controlled, which favors prompt definitive treatment. **S**

## Recommendations

1. Radioactive iodine as definitive treatment: it is effective, quick, and avoids long-term antithyroid drug risks. Long-term methimazole is less suitable because relapse after stopping is common, and surgery is not needed without a large goiter, compressive symptoms, or eye disease. Iodine-131, 15 mCi, booked for next week.
2. Stop methimazole three days before treatment; restarting it afterwards is not needed while free T4 is only mildly raised and he is on a beta-blocker.
3. Continue metoprolol until he is no longer thyrotoxic, then taper.
4. No steroid cover; report any eye symptoms promptly.
5. Free T4 and total T3 within one to two months of treatment, then every four to six weeks until stable.
6. Hypothyroidism is expected within two to three months. Start levothyroxine once free T4 falls below normal, at a dose below full replacement because of his age and recent atrial fibrillation, and titrate by TSH every four to eight weeks to 0.4 to 4.0 mIU/L.
7. Reassess anticoagulation once he is no longer thyrotoxic and sinus rhythm has been confirmed on ambulatory monitoring.
8. Written radiation-safety instructions for the first week after treatment.

## Strengths and supports

- Supports: spouse, adult children, and close colleagues and friends **S**

## Communication

Discussed with Dr. Whitford the same day; the patient agrees with radioactive iodine and the follow-up plan. **S**

## Follow-up

Endocrinology will give the radioactive iodine next week. Primary care will monitor thyroid levels and levothyroxine dosing on the CMID hypothyroidism schedule. Endocrinology will see him again for eye symptoms, persistent hyperthyroidism at six months, or difficulty reaching the TSH target. **S**

## Guideline basis

- 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (2023), American College of Cardiology, American Heart Association, American College of Chest Physicians, and Heart Rhythm Society (Circulation 2024;149(1):e1-e156)
- 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016), American Thyroid Association (Thyroid 2016;26(10):1343-1421)
- Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014), American Thyroid Association (Thyroid 2014;24(12):1670-1751)
- CMID: Clinical Monitoring Intelligence Database, atrial fibrillation and hypothyroidism monographs (2026), Aether Forge
